GATS Activators are a diverse set of chemical compounds that enhance the functional activity of GATS through various biochemical mechanisms. Forskolin, for instance, increases cAMP levels, indirectly boosting GATS activity via PKA, which can phosphorylate proteins affecting GATS's functional state. Similarly, PMA, as a PKC activator, and Ionomycin, a calcium ionophore, both raise intracellular signaling molecules that lead to the activation of kinases which can phosphorylate and thereby enhance the activity of GATS. The lipid signaling molecule Sphingosine-1-phosphate is known for its ability to bind G protein-coupled receptors and initiate downstream kinase cascades, which could lead to the modulation of GATS through phosphorylation. A23187 also elevates intracellular calcium and may activate calcium/calmodulin-dependent kinases that enhance GATS function. Additionally, LY294002, by inhibiting PI3K, may shift signaling pathways in a way that compensates with enhanced GATS activity, while U0126 and SB203580, by inhibiting MEK1/2 and p38 MAP kinase respectively, can lead to the enhancement of GATS through alternative signaling mechanisms.
Epigallocatechin gallate (EGCG) and Anisomycin modulate kinase signaling, with EGCG showing potential to affect kinase pathways that regulate GATS and Anisomycin activating stress-related kinases, possibly leading to enhanced GATS activity. Okadaic Acid, a protein phosphatase inhibitor, raises the phosphorylation level of cellular proteins,which could lead to an increase in GATS activity due to the resultant shift in the phosphorylation balance. Dibutyryl cAMP acts similarly to endogenous cAMP by activating PKA, thus mimicking the natural activation process of GATS via cAMP-mediated pathways. Collectively, these GATS Activators employ a spectrum of molecular events to amplify the functional activity of GATS, leveraging intracellular signaling cascades that involve phosphorylation, dephosphorylation, and the modulation of kinase activities, which together foster a conducive environment for the upregulated activity of GATS without necessitating changes in its gene expression or direct activation.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which can enhance GATS activity by downstream activation of PKA. PKA phosphorylates various substrates that can modulate the functional state of GATS. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases might phosphorylate GATS or associated regulatory proteins, thereby enhancing GATS activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate GATS or associated proteins, leading to enhanced GATS activity through PKC-mediated signal transduction pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its G protein-coupled receptors, which can lead to the activation of downstream kinases and phosphatases that modulate GATS activity by altering its phosphorylation state. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium and potentially activating calcium/calmodulin-dependent protein kinases, which can enhance the functional activity of GATS. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases (PI3K), which can alter the activity of downstream signaling pathways and indirectly enhance the activity of GATS by shifting the balance of phosphorylation events. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG has kinase inhibitory effects and can modulate signal transduction pathways, thereby potentially enhancing GATS activity by affecting proteins that regulate GATS function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, thereby potentially reducing the activity of ERK signaling. This inhibition may lead to a compensatory enhancement of GATS activity through alternative signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase, which can lead to alterations in signaling pathways that indirectly enhance GATS activity through changes in cellular stress responses. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases, like JNK, which can modulate GATS activity through stress and inflammatory signaling pathways that affect GATS function. | ||||||